Persantin Retard 200mg
PERSANTIN® RETARD 200 MG
(dipyridamole)
PACKAGE LEAFLET: INFORMATION FOR THE USER
Your medicine is available using the name PERSANTIN RETARD 200 MG, but will be referred to as PERSANTIN Retard throughout the leaflet.
Read all of this leaflet carefully before you start taking this medicine.
■ Keep this leaflet. You may need to read it again.
■ If you have any further questions, ask your doctor or pharmacist.
■ This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
■ If any of the side effects gets troublesome or serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What PERSANTIN Retard is and what it is used for
2. Before you take PERSANTIN Retard
3. How to take PERSANTIN Retard
4. Possible side effects
5. How to store PERSANTIN Retard
6. Further information
1. WHAT PERSANTIN RETARD IS AND WHAT IT IS USED FOR
The name of your medicine is PERSANTIN Retard.
It contains a medicine called Dipyridamole. This belongs to a group of medicines called 'anti-thrombotic agents', which are used to help stop blood clots forming.
PERSANTIN Retard is used:
■ To help stop blood clots which may occur if you have had your heart valves replaced.
■ In people who have had a stroke caused by a blood clot in the brain. This medicine reduces the risk of having another stroke.
2. BEFORE YOU TAKE PERSANTIN RETARD
Do not take PERSANTIN Retard if you are allergic (hypersensitive) to:
■ Dipyridamole
■ Any of the other ingredients of PERSANTIN Retard (see section 6: Further Information)
Take special care with PERSANTIN Retard
Check with your doctor or pharmacist before taking your medicine if:
■ You have angina or other heart problems (including heart valve or circulation problems) or have had a recent heart attack
■ You have myasthenia gravis (a rare muscle problem)
■ You have any bleeding problems
■ You are pregnant or planning to become pregnant or are breast-feeding.
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking PERSANTIN Retard.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This includes herbal medicines. This is because PERSANTIN Retard can affect the way some other medicines work. Also some other medicines can affect the way PERSANTIN Retard works.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
■ Medicines for high blood pressure
■ Medicines for muscle weakness such as something called a 'cholinesterase inhibitor'
■ Aspirin (or planning to take aspirin for any condition)
■ Adenosine injection - used for heart problems or tests on the heart
■ Warfarin or other medicines to stop blood clots forming. If so, tell them at your next visit to the anticoagulant clinic that you are now taking PERSANTIN Retard.
If you are having heart tests
PERSANTIN Retard contains dipyridamole.
Dipyridamole is also sometimes given as an injection during tests to see if the heart is working properly (also called 'myocardial imaging'). This means that the test and your medicine may contain the same substance. If you are going to have an injection of dipyridamole, tell the doctor that you are taking PERSANTIN Retard.
Pregnancy and breast-feeding
■ Tell your doctor if you are pregnant or planning to get pregnant.
■ Tell your doctor if you are breast-feeding as PERSANTIN Retard should only be used during breast-feeding if your doctor considers it essential.
Driving and using machines
You may feel dizzy while taking PERSANTIN Retard. If this happens do not drive or use any tools or machines.
3. HOW TO TAKE PERSANTIN RETARD
Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
The usual dose is:
■ One capsule twice a day
■ Usually one in the morning and one in the evening
■ It is best to take it with food
■ Swallow the capsule whole
■ Do not crush or chew it
Do not give to children.
If you take more PERSANTIN Retard than you should
If you take more of this medicine than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you, even if there are no capsules left.
If you forget to take PERSANTIN Retard
■ If you forget a dose, take it as soon as you remember it
■ However, if it is time for the next dose, skip the missed dose
■ Do not take a double dose to make up for the forgotten dose
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines PERSANTIN Retard can cause side effects, although not everybody gets them.
Allergic reactions
If you have an allergic reaction, stop taking your medicine and see a doctor straight away. The signs may include feeling breathless, runny nose, severe rash with itching, swelling and swelling around the eyes.
Other side effects that have been reported for PERSANTIN Retard are described below. They are listed as either very common, common or not known.
Very common (affects more than 1 in 10 people)
■ Headache
■ Feeling dizzy
■ Feeling sick (nausea)
■ Diarrhoea
Common (affects less than 1 in 10 people but more than 1 in 100 people)
■ Muscle pain
■ Being sick (vomiting)
■ Worsening of the symptoms of heart disease such as chest pain and shortness of breath
Not Known
■ Hot flushes
■ Lowering of blood pressure or increased heart rate
■ A blood problem called 'thrombocytopenia' which can cause bruising and prolonged bleeding from wounds, including during or after surgery
In people who have gallstones, the dipyridamole in this medicine can be absorbed into the gallstones.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.aov.uk/vellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE PERSANTIN RETARD
The capsules should not be used after the expiry date, which is printed on the packaging. The expiry date refers to the last day of that month.
Do not store PERSANTIN Retard above 25°C. Store in the original container.
Do not open the container until you are ready to start taking the capsules. Discard any remaining capsules 6 weeks after first opening. Any unused capsules should either be discarded safely or returned to your pharmacist.
KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
If your capsules appear to be discoloured or show any other signs of deterioration, please return to your pharmacist who will advise you.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. FURTHER INFORMATION
What PERSANTIN Retard contains
The active substance is dipyridamole. Each modified release capsule contains 200 mg dipyridamole as the active ingredient. PERSANTIN Retard is a modified release capsule which releases the active ingredient slowly in your body over a number of hours.
The capsules contain the following inactive ingredients: tartaric acid, povidone, methacrylic acid-methyl methacrylate copolymer (1:2), talc, hypromellose, hypromellose phthalate, triacetin, dimeticone, stearic / palmitic acid, gelatin, acacia, titanium dioxide (E171), red iron oxide (E172), and yellow iron oxide (E172).
What PERSANTIN Retard looks like and contents of the pack
PERSANTIN Retard are hard gelatin capsules consisting of a red opaque cap and an orange opaque body, with no markings.
PERSANTIN Retard is available in packs containing 60 capsules.
Manufacturer
PERSANTIN Retard is manufactured by: Boehringer Ingelheim Pharma GmbH & Co. KG, D-88397 Biberach an der Riss, Germany.
Procured from within the EU and repackaged by: Doncaster Pharmaceuticals Group Ltd, Kirk Sandall, Doncaster, DN3 1QR.
Product Licence holder: Doncaster Pharmaceuticals Group Ltd,
Kirk Sandall, Doncaster DN3 1QR.
|POM| PL No: 04423/0488
Leaflet revision and issue dated (Ref): 11.02.15
Persantin® is a registered trademark of Boehringer Ingelheim Pharma GmbH 81 Co. KG
Page 2 of 2